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Cutaneous manifestations are common and often the presenting feature of human immunodeficiency virus
(HIV) infection, but a comprehensive study of HIV-associated skin lesions is not available in Taiwan. We
reviewed all skin lesions in all HIV patients diagnosed in our department between 1990 and 1998 to
document the spectrum of skin manifestations, the frequency of each disorder, and their relationship with
CD4 counts. A total of 64 HIV patients were studied, including 38 with acquired immunodeficiency
syndrome (AIDS) (CD4 < 200 × 106 cells/L) and 26 who had not developed AIDS (non-AIDS). There were
142 episodes of skin conditions representing 25 different skin diseases, including oral candidiasis
(15% in non-AIDS vs 71% in AIDS patients), drug eruptions, herpes simplex, seborrheic dermatitis,
dermatophytosis, herpes zoster, secondary syphilis, condyloma acuminatum, Kaposi’s sarcoma (16%
among AIDS patients), hairy leukoplakia, and molluscum contagiosum (13% among AIDS patients), in
decreasing order. Several unusual cases are briefly described, including verrucous herpes infection,
condyloma-like molluscum contagiosum, and AIDS-associated pigmented erythroderma. In our study,
70% of all HIV patients had skin diseases, with an average of 2.2 conditions per patient (3.2 in AIDS patients
vs 0.7 in non-AIDS patients; p < 0.001). A broad spectrum of HIV-associated skin diseases was observed
in our series. The frequency of HIV-associated skin disease was 92% in AIDS patients and 39% in non-
AIDS patients; 78% of skin lesions in AIDS patients were diagnosed when CD4 counts were below
100 × 106 cells/L.
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The acquired immunodeficiency syndrome (AIDS) caused
by human immunodeficiency virus (HIV) infection was
first described in North America in 1980, rapidly followed
by a worldwide epidemic. In Taiwan, the first case of AIDS
was reported in 1984. Since then, the number of reported
cases has increased rapidly from 41 new cases of HIV
infection and seven cases of AIDS in 1990 to 384 and 135
cases, respectively, in 1997, a remarkable 20% annual in-
crement [1]. The infection rate in 2001 was almost double
that in 1997 [1]. In HIV infection, host immunity deterio-
rates significantly when the CD4 count drops below 200 ×
106 cells/L. At this stage, the infection is classified as AIDS
according to the 1993 Centers for Disease Control classifi-
cation [2].
HIV infection is commonly associated with various
mucocutaneous manifestations, including opportunistic
infections, neoplasms, pruritus, and adverse drug reac-
tions (ADR) [3,4]. These disorders occur with increasing fre-
quency as the immune function deteriorates, and are prob-
lematic in more than 90% of HIV-infected individuals [5].
The occurrence of certain cutaneous disorders correlates
with low CD4 cell counts (200–300 × 106 cells/L), including
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Kaposi’s sarcoma (KS), oral hairy leukoplakia, multiple fa-
cial molluscum contagiosum, chronic herpes virus infec-
tion, protozoa infections, fungal infections, mycobacterial
infections, xerosis, and oropharyngeal candidiasis [6]. Of
these, oral candidiasis, hairy leukoplakia, and KS are
regarded as important clinical markers of AIDS.
Dermatologists are often the first physicians to diagnose
and treat HIV-associated skin diseases, and so must be
aware of its ever-broadening spectrum. As AIDS progresses,
these skin diseases may become more severe and refractory
to therapy. Diagnosis and treatment may be difficult due to
atypical presentation, mixed infections or occurrence at
unusual sites. A high index of suspicion and judicious use
of laboratory tests, especially skin biopsy, are essential.
HIV-associated mucocutaneous manifestations have not
been well documented in Taiwan, although AIDS-associated
KS has been reported [7]. The purpose of this study was to
describe the clinical spectrum and prevalence of various
mucocutaneous disorders in all patients with HIV infection
seen in a national teaching hospital.
MATERIALS AND METHODS
All patients with HIV infection seen in the Department of
Dermatology, National Cheng Kung University Hospital
(NCKUH), from January 1990 to January 1998 were included
in this study. All patients underwent complete dermatologic
examinations, primarily by the same dermatologist (JYYL).
Most patients were followed on a regular basis at derma-
tology clinics, but some were seen only sporadically. All
mucocutaneous lesions were recorded. In some patients,
diagnoses were further confirmed by appropriate scrapings,
cultures, or biopsies when indicated. Most patients received
two- or three-drug combined antiviral therapy. Clinical
records and photos were reviewed and the following data
were collected: age, gender, potential risk factors for HIV
infection, including sexual preference, drug history, and
the nearest CD4 cell counts when a specific skin condition
was diagnosed.
Statistical analysis
Fisher’s exact test (two-tailed) was used to compare the
number of patients with each skin disease between AIDS
and non-AIDS patients, and 95% confidence intervals were
calculated. All p values were two-sided, and p values less
than 0.05 were considered statistically significant. SAS
statistical software version 6.12 (SAS Institute Inc, Cary,
NC, USA) was used.
RESULTS
Study population
The 64 patients with HIV infection included 61 males and
three females aged 17 to 69 years (mean, 40 years). Of these,
38 had AIDS (CD4 < 200 × 106 cells/L) and 26 did not (non-
AIDS). The AIDS group included two patients whose HIV
infection evolved to AIDS during the observation period.
Of the AIDS patients, 44.7% were homosexual or bisexual;
58% of AIDS patients died of AIDS during the observation
period (Table 1). There was no significant difference in age,
gender, and sexual preference between AIDS and non-
AIDS patients. Only one patient, a homosexual man, was an
intravenous drug abuser. No patients had hemophilia. In
two patients (one man and one woman), the infection was
traced back to bone grafts procured from a man who had
not been screened for HIV when they underwent orthopedic
surgery in a local hospital. One of these cases has been
reported previously [8].
Skin findings
A total of 142 episodes of skin conditions representing 25
different mucocutaneous diseases were documented in 45
Table 1. Demographic data for 64 HIV-infected patients in Taiwan, between 1990 and 1998
Non-AIDS (n = 26) AIDS (n = 38) p
Mean age ±  SD, yr 37.58 ±  15.05 33.39 ±  9.99 0.19
Male, n (%) 23 (88.5) 38 (100.0) 0.06
Sexual preference, n (%) 0.79
Heterosexual 16 (61.5) 21 (55.3)
Bisexual/homosexual 10 (38.5) 17 (44.7)
Died of AIDS 0 (0) 22 (57.9) < 0.001
AIDS = acquired immunodeficiency syndrome; SD = standard deviation.
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patients (70%) (Table 2). No skin disease was recorded in
the other 19 patients (3 AIDS and 16 non-AIDS patients). Of
the 142 episodes, 123 occurred in AIDS patients. The average
number of skin conditions per patient was 0.7 and 3.2 in
non-AIDS and AIDS patients, respectively. In the AIDS
group, 97 of the 123 skin conditions (79%) were diagnosed
when the CD4 counts were below 100 × 106 cells/L. An
increasing number of skin diseases was associated with a
CD4 count below 100 × 106 cells/L as well as a diagnosis of
AIDS (p < 0.001).
The prevalence of infectious disease was six-fold higher
in AIDS than in non-AIDS patients. Recurrent herpes
simplex infection was the most common viral infection,
mostly seen in AIDS patients. Chronic herpes simplex
infection with unusual hyperkeratotic lesions was observed
in a 29-year-old heterosexual man with AIDS. The infection
initially manifested as vesicular herpetic lesions in the groin
area. After three episodes of dissemination over a 2-year
period, five of the lesions on the forehead and trunk became
persistent with a hyperkeratotic surface (Figure 1). Skin
biopsy revealed hyperkeratosis of the epidermis and
follicular infundibula with many necrotic multinucleated
giant keratinocytes, consistent with herpes simplex or
varicella zoster virus infection. Molluscum contagiosum
Table 2. Cutaneous manifestations among HIV-infected Taiwanese, in non-AIDS (n = 26) and AIDS (n = 38) patients
Non-AIDS, n (%) AIDS, n (%) p
Total skin conditions observed 19 123 < 0.001
Subjects with any skin disease 10 (38.5) 35 (92.1) < 0.001
Infection
Viral infection
Herpes simplex 2 (7.7) 12 (31.6) 0.031
Herpes zoster 1 (3.8) 8 (21.1) 0.071
Condyloma acuminatum 2 (7.7) 5 (13.2)
Hairy leukoplakia 0 (0) 5 (13.2) 0.074
Molluscum contagiosum 0 (0) 5 (13.2) 0.074
Fungal infection
Oral candidiasis 4 (15.4) 27 (71.1) < 0.001
Dermatophytosis 0 (0) 10 (26.3) < 0.001
Cryptococcosis, skin 0 (0) 1 (2.6)
Tinea versicolor 0 (0) 1 (2.6)
Bacterial infection
Syphilis 4 (15.4) 5 (13.2) 0.387
Cellulitis 0 (0) 4 (10.5) 0.140
Furunculosis 0 (0) 1 (2.6)
Parasite infestation
Scabies 1 (3.8) 0 (0)
Dermatoses
Seborrheic dermatitis 2 (7.7) 12 (31.6) 0.031
Drug eruption 1 (3.8) 14 (36.8) < 0.001
Morbilliform drug eruption 1 (3.8) 9 (23.7) 0.039
Erythema multiforme 0 (0) 1 (2.6)
Stevens-Johnson syndrome 0 (0) 1 (2.6)
Photosensitive dermatitis 0 (0) 1 (2.6)
Erythroderma 0 (0) 2 (5.3)
Eosinophilic pustular folliculitis 1 (3.8) 3 (7.9) 0.387
Acquired ichthyosis 1 (3.8) 2 (5.3) 0.731
Pruritic papular eruption 0 (0) 1 (2.6)
Prurigo nodularis and vitiligo 0 (0) 1 (2.6)
Psoriasis and hypertrichosis 0 (0) 1 (2.6)
Neoplasm
Kaposi’s sarcoma 0 (0) 6 (15.8) 0.073
AIDS = acquired immunodeficiency syndrome.
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was diagnosed in five AIDS patients; two manifested
grouped or coalescing papular lesions over the anogenital
areas, mimicking condyloma acuminatum clinically. The
diagnosis was confirmed by skin biopsy.
The most common fungal infection was oral candidia-
sis, found in 31 patients, 27 of them with AIDS. The infection
was often very extensive, sometimes combined with dys-
phagia due to esophageal involvement. Dermatophytosis
of the skin and/or the nail was recorded in 10 patients, all
with AIDS. One had a superficial white pattern of ony-
chomycosis. A 19-year-old homosexual man with AIDS
had systemic and cutaneous cryptococcal infection mani-
festing numerous molluscum contagiosum-like, shiny,
flesh-colored papules on the face, ears, and upper arms.
Cryptococcosis was diagnosed clinically and confirmed by
crush smear, skin biopsy, and fungal culture of the skin
lesions. Central nervous system infection was confirmed by
cerebrospinal fluid culture. Syphilis was the most commonly
recorded bacterial infection, but there was no significant
difference between AIDS and non-AIDS patients.
The dermatoses observed in our patients included
seborrheic dermatitis, ADR, HIV-associated eosinophilic
folliculitis (HIV-EF), pruritic papular eruption of AIDS,
acquired ichthyosis, and psoriasis with hypertrichosis
of the eyelashes. Three of the four patients with HIV-EF
had AIDS. Progressive generalized vitiligo was noted in a
heterosexual man with AIDS who also suffered from wide-
spread, recalcitrant prurigo nodularis with secondary
bacterial infection (Figure 2).
Fifteen episodes of drug eruptions were recorded in
11 patients, including morbilliform rash (10 episodes),
erythroderma (2 episodes in 2 patients), photosensitive
dermatitis, erythema multiforme, and Stevens-Johnson
syndrome. Sulfamethoxazole-trimethoprim (SMX-TMP)
was suspected to be the cause in seven episodes. One pa-
tient, a homosexual man, developed pigmented erythro-
derma 1 month after an episode of erythema multiforme
caused by SMX-TMP (Figure 3). His CD4 count was 19 ×
106 cells/L and tests for human T-cell leukemia virus
(HTLV)-1 antibody were negative. Histopathology of the
erythroderma revealed a lichenoid lymphohistiocytic
infiltrate with melanophages and epidermotropism of
atypical lymphoid cells with convoluted nuclei and necro-
tic keratinocytes. In addition, there was perifollicular
granulomatous infiltrate containing Langhan’s giant cells.
AIDS-associated KS was diagnosed in six men, four of
whom were homosexual and two heterosexual. Five patients
had disseminated KS skin lesions, primarily involving the
face, scalp, and chest. Other organs affected included the
oral mucosa in three patients, lung in two, and larynx and
gastrointestinal tract in one each. A 41-year-old homosexual
man had extensive KS involving the face and scalp (Figure
4). Interferon alpha-2b (Intron-A®; Schering-Plough, Cork,
Ireland) and radiotherapy were only partially effective.
Paclitaxel (Taxol®; Bristol-Myers Squibb Company, Puerto
Rico) was able to induce a remission lasting more than 1
year, but the patient eventually died of a severe relapse with
rapid progression of KS lesions.
DISCUSSION
In the present study, a total of 142 episodes of skin conditions
representing 25 different diseases were observed in 64
Figure 1. (A) Verrucous lesion on the forehead of a heterosexual man
with AIDS. (B) Histopathology reveals hyperkeratosis of the epidermis
and follicular infundibula with many necrotic, multinucleated giant
keratinocytes. (C) Close-up view of an affected follicle with characteristic
multinucleated keratinocytes (hematoxylin & eosin, B × 40, C × 200).
C A
B
Figure 2. A heterosexual man presented with generalized prurigo
nodularis followed by rapidly progressive and generalized vitiligo.
(A) Note the intercurrent photodermatitis due to sulfamethoxazole-
trimethoprim. (B) Close-up view of the lesions on the right forearm.
B A
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Figure 3. (A) A homosexual man
developed pigmented erythroderma
following erythema multiforme caused
by sulfamethoxazole-trimethoprim.
(B) Histopathology of the erythroder-
ma reveals a lichenoid lymphohis-
tiocytic infiltrate with melanophages
and epidermotropism of lymphoid
cells, some with atypical convoluted
nuclei. (C) In addition, there is peri-
follicular granulomatous infiltrate
containing Langhan’s giant cells
(hematoxylin & eosin, B × 100, C ×
100).
B A C
patients with HIV infection; 87% were diagnosed in AIDS
patients. Skin diseases were observed in 38.5% of the non-
AIDS group and 92% of the AIDS group. The difference in
prevalence of skin diseases between AIDS and non-AIDS
patients was significant (p < 0.001) (Table 2). Of the AIDS
patients with skin diseases, 78% had a CD4 count less than
100 × 106 cells/L. Previous studies have suggested that
between 5% and 20% of individuals with HIV infection will
develop AIDS over a 3-year period [9]. Two of 28 patients
developed AIDS in our series. The mode of transmission in
our series was unusual in that two patients contracted HIV
infection during the same period of time at the same local
hospital through bone grafts procured from a man who had
not undergone HIV screening. Transmission of HIV through
bone transplantation is rare, and these two cases represent
the first such cases in Taiwan. One of these cases has been
reported previously [8].
Many of the HIV-associated cutaneous disorders re-
flected the progression of HIV infection as the CD4 cell
count decreased [10]. Goodman et al reported a prevalence
of 1.5 skin disease episodes per patient in AIDS patients [4].
In another series reported by Kaplan et al [3], 103 of the 118
HIV-patients with a CD4 count less than 100 × 106 cells/L
developed a total of 193 skin conditions, an average of 1.6
conditions per patient. Of the 104 patients with a CD4 count
more than 100 × 106 cells/L, 40 had a total of 40 conditions,
an average of 0.4 conditions per patient. In 1993, Coopman
et al reported cutaneous diseases in a large series of HIV-
infected patients; they found that 79% of patients had one
or more dermatologic diagnoses [11]. Uthayakumar et al
reported 2.1 skin conditions per AIDS patient over a 4-
month period [12]. In our study, 70% of HIV patients had
skin diseases, an average of 2.2 conditions per patient, but
cutaneous manifestations were significantly more com-
mon in AIDS patients, with an average of 3.2 conditions per
patient compared to 0.7 conditions per patient in non-AIDS
patients.
Skin manifestations in HIV-infected patients among
different populations reported from Asian (Chinese,
Malaysian and Indian populations) and Western countries
(France and USA) [6,11,13–15] are summarized in Table 3.
The distribution of skin manifestations differs among various
studies. The Malaysian and Indian studies reported lower
rates of herpes simplex and KS but higher rates of xerosis,
pruritic papular eruption and prurigo nodularis [6,14,15],
compared with the French and US reports [11,13] and the
present study. On the other hand, the US study reported a
lower rate of oral candidiasis and the French study reported
a lower rate of drug eruptions, compared with our study.
Interestingly, the Indian reports gave no data on drug erup-
tions. Overall, the distribution pattern of skin manifesta-
Figure 4. (A) A homosexual man with extensive Kaposi’s sarcoma
lesions involving the face and scalp. (B) The lesions resolved after
paclitaxel therapy.
B A
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Table 3. Comparison of skin manifestations among HIV-infected patients in different populations
Taiwan Malaysia15 Malaysia6 India14 France13 USA11
(n = 64) (n = 145 Chinese) (n = 182) (n = 833)  (n = 450) (n = 684)
Infection
Viral infection
Herpes simplex 21.9% 2.1% 1.6% 7.7% 24.4% 11.7%
Herpes zoster 14.1% 3.4% 2.7% 11.2% 26.9% 23.3%
Condyloma acuminatum 10.9% 2.1% 3.3% 1.2% 6.0% 4.3%
Hairy leukoplakia 7.8% 2.8% 3.3% 2.3% 10.4% 4.2%
Molluscum contagiosum 7.8% 2.1% 1.6% 1.3% 5.1% 38.0%
Fungal infection
Oral candidiasis 48.4% 35.9% 35.7% 45.0% 44.7% 16.9%
Dermatophytosis 15.6% 9.7% 9.9% 8.0% 3.6% 4.8%
Cryptococcosis, skin 1.6%
Tinea versicolor 1.6% 1.1%
Bacterial infection
Syphilis 12.5% 1.3%
Cellulitis 6.3% 3.4% 2.7% 2.9% 3.5%
Furunculosis 1.6% 2.1% 3.3% 4.4%
Parasite infestation
Scabies 1.6% 1.4% 1.1% 0.5% 0.4% 13.0%
Dermatoses
Seborrheic dermatitis 21.9% 20.7% 19.2% 14.0% 4.3%
Drug eruption 23.4% 2.1% 1.6% 2.9% 27.5%
Eosinophilic pustular folliculitis 6.3%
Xerosis 4.7% 27.6% 27.5% 10.4% 2.5%
Pruritic papular eruption 1.6% 29.7% 29.1% 7.7% 8.7% 12.0%
Prurigo nodularis 1.6%
Psoriasis 1.6% 8.3% 7.7% 1.8% 3.5%
Neoplasm
Kaposi’s sarcoma 9.4% 0.7% 0.5% 0.1% 9.1% 6.9%
tions in our series seems to be closer to those of the Western
series than to those of the three Asian populations, inclu-
ding a Chinese population in Malaysia [6,14,15]. We are
not aware of any report on the distribution of skin diseases
in the general Taiwanese population, except for a study
on patients older than 65 years [16], which reported that
the most common cutaneous disorders were dermatitis
(58.7%), followed by fungal infections (38.0%), pruritus
(14.2%), benign tumors (12.8%), and viral infections
(12.3%).
Skin infections were the most common problem en-
countered in our study and were six-fold more common in
the AIDS group than the non-AIDS group. Oral candidiasis
was found in 71% of AIDS patients, which was similar to
other studies [4,6,11]. Dermatophytosis was diagnosed in
15.6% of HIV-infected patients in our series, with a significant
difference in the frequency of dermatophytosis between the
AIDS and non-AIDS groups (p < 0.001). The frequency of
dermatophytosis is higher than in Western countries (3.6–
4.8%) [4,11,13], but is comparable to that in two Asian
reports (8.0–9.9%) [6,14]. Viral infections were mainly caused
by the herpes virus family. Herpes simplex and herpes
zoster were found in 31.6% and 21.1% of AIDS patients,
respectively, in our series. Herpes simplex infection was
more frequent in AIDS than in non-AIDS patients (p < 0.05).
Except for secondary syphilis, cutaneous bacterial infection
was relatively uncommon in our series. No case of atypical
mycobacterial infection of the skin or bacillary angiomatosis
was observed.
The AIDS group had an eight-fold higher incidence of
dermatoses than the non-AIDS group. Most dermatoses
were significantly more frequent in patients with CD4 cell
counts less than 100 × 106 cells/L. Seborrheic dermatitis was
the most common dermatosis (21.8%) in our series and was
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more commonly seen in the AIDS group than the non-AIDS
group (p < 0.05). HIV-EF is a type of sterile folliculitis
characterized by chronic pruritic, discrete, wheal-like,
papular lesions on the trunk and extremities. It is probably
the most common form of folliculitis seen in HIV-infected
patients. Histopathology shows an eosinophil-rich follicu-
lar and perifollicular inflammatory infiltration [17]. Pruritic
papular eruption in AIDS is regarded as a variant of HIV-
EF. HIV-EF needs to be differentiated from steroid acne,
pityrosporum folliculitis, and insect bite reaction. It is likely
that HIV-EF was under-diagnosed, as the diagnosis requires
a skin biopsy. Psoriasis tends to be more severe in AIDS
[18], but we did not see this in our patient with psoriasis.
Patients with AIDS are at increased risk for cutaneous
ADR, about 10 times higher than the general population
[18]. This might be due to the frequent drug administration
or low CD4 cell counts. In our series, ADR occurred in
36.8% of AIDS patients, much more frequent than in non-
AIDS patients (p < 0.001). Of drug eruptions, 41% were
suspected to be caused by SMX-TMP used to treat or
prevent Pneumocystis carinii pneumonia. Our result con-
firmed the high incidence of eruptions caused by SMX-
TMP in AIDS patients [19].
KS occurs mostly as a late manifestation of HIV infection
and correlates with advanced deterioration of cellular
immunity [20]. HIV-associated KS typically involves the
face, oral mucosa, and upper part of the body, in contrast to
the lower extremity involvement in classical KS. KS has
been reported in 4.5% to 9.1% of HIV patients [4,12,13,21],
and is diagnosed in up to 36% of homosexual AIDS patients
[22]. However, the incidence has decreased since the
introduction of highly active antiretroviral therapy [13,21].
In the present study, KS occurred in 9.4% of HIV-infected
patients and in 15.8% of AIDS patients, in contrast to the
extreme rarity in other Asian populations (< 1%) [6,14,15].
The HIV-associated cutaneous diseases in our series en-
compassed a broad spectrum of skin diseases. Moreover,
several cases displayed unusual features. Herpes simplex
infection is common in AIDS patients and may manifest
chronic anogenital or perioral ulcerative lesions or verrucous
lesions [23]. In addition, cytomegalovirus infection and
molluscum contagiosum have also been associated with
verrucous lesions [24]. Verrucous herpes virus infection in
one of our AIDS patients was presumably caused by herpes
simplex as the lesions were preceded by disseminated
herpes simplex infection from the groin area. Molluscum
contagiosum is usually easy to diagnose because of its
characteristic umbilicated waxy papules, but it should be
differentiated from disseminated papular lesions of
cryptococcosis and anogenital condyloma acuminatum.
Cryptococcosis is relatively common in AIDS, with a
prevalence of 6% to 13% [24]. The central nervous system
and skin are affected in about 80% and 5% of cases,
respectively. In cases with skin involvement, 25% present
with cutaneous lesions, half of which are molluscum
contagiosum-like, as seen in one of our patients. While
papular cryptococcal skin lesions simulating molluscum
contagiosum is well documented, anogenital molluscum
contagiosum mimicking condyloma acuminatum appears
to be less well known.
One of our HTLV-1 negative patients with AIDS
developed hyperpigmented erythroderma after an epi-
sode of erythema multiforme. The histopathology was
characterized by a lichenoid infiltrate with epidermotro-
pism of atypical lymphoid cells. Similar findings have been
reported in AIDS-associated pigmented erythroderma,
pseudo-Sézary syndrome [25], or mycosis fungoides-like
erythroderma [26]. In addition to the Sézary syndrome-like
features, our case also had a granulomatous component in
the infiltrate. This feature is suggestive of granulomatous
mycosis fungoides, which has been reported in one HIV
patient previously [27].
CONCLUSION
A broad spectrum of HIV-associated skin diseases was
observed in our series, occurring mostly in AIDS patients
(AIDS 92% vs non-AIDS 39%); 78% of skin lesions in AIDS
patients were diagnosed when CD4 counts were below
100 × 106 cells/L. Many of the skin diseases, including
herpes simplex infection, hairy leukoplakia, oral candidia-
sis, seborrheic dermatitis, drug eruptions, eosinophilic fol-
liculitis, and KS, were either more commonly or exclusive-
ly seen in AIDS patients. These findings are comparable
to the data reported in several large series. It would be
interesting to study the impact of the recent introduction
of new antiviral drug therapies on the prevalence and
spectrum of HIV-associated skin disorders.
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